AAAAAA
Results: 1-25/110
Authors:
TALPAZ M
KURZROCK R
KANTARJIAN H
Citation: M. Talpaz et al., THE CLINICAL IMPACT OF INTERFERON USAGE IN HEMATOLOGIC MALIGNANCIES, European cytokine network, 9(3), 1998, pp. 5018-5018
Authors:
FAYAD L
CABANILLAS F
TALPAZ M
MCLAUGHLIN P
KURZROCK R
Citation: L. Fayad et al., HIGH SERUM INTERLEUKIN-6 LEVELS CORRELATE WITH A SHORTER FAILURE-FREESURVIVAL IN INDOLENT LYMPHOMA, Leukemia & lymphoma, 30(5-6), 1998, pp. 563-571
Authors:
FERRAJOLI A
TALPAZ M
KURZROCK R
HARRIS D
VAN Q
ESTEY EH
ESTROV Z
Citation: A. Ferrajoli et al., THROMBOPOIETIN STIMULATES MYELODYSPLASTIC SYNDROME GRANULOCYTE-MACROPHAGE AND ERYTHROID PROGENITOR PROLIFERATION, Leukemia & lymphoma, 30(3-4), 1998, pp. 279-292
Authors:
CORTES J
KANTARJIAN H
OBRIEN S
KURZROCK R
KEATING M
TALPAZ M
Citation: J. Cortes et al., GM-CSF CAN IMPROVE THE CYTOGENETIC RESPONSE OBTAINED WITH INTERFERON-ALPHA THERAPY IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA, Leukemia, 12(6), 1998, pp. 860-864
Authors:
KURZROCK R
TALPAZ M
BERAN M
HARRIS D
ESTROV Z
Citation: R. Kurzrock et al., DNA IN-SITU HYBRIDIZATION OF INDIVIDUAL COLONIES TO DETERMINE LINEAGEDERIVATION IN LEUKEMIA, Leukemia, 12(2), 1998, pp. 242-246
Authors:
KURZROCK R
ESTROV Z
KANTARJIAN H
TALPAZ M
Citation: R. Kurzrock et al., CONVERSION OF INTERFERON-INDUCED, LONG-TERM CYTOGENETIC REMISSIONS INCHRONIC MYELOGENOUS LEUKEMIA TO POLYMERASE-CHAIN-REACTION NEGATIVITY, Journal of clinical oncology, 16(4), 1998, pp. 1526-1531
Authors:
ESTROV Z
TALPAZ M
KU S
HARRIS D
VAN Q
BERAN M
HIRSCHGINSBERG C
HUH Y
YEE G
KURZROCK R
Citation: Z. Estrov et al., Z-138 - A NEW MATURE B-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA CELL-LINE FROM A PATIENT WITH TRANSFORMED CHRONIC LYMPHOCYTIC-LEUKEMIA, Leukemia research, 22(4), 1998, pp. 341-353
Authors:
KURZROCK R
ESTROV Z
KU S
LEONARD M
TALPAZ M
Citation: R. Kurzrock et al., INTERLEUKIN-1 INCREASES EXPRESSION OF THE LYT-10 (NF-KAPPA-B2) PROTOONCOGENE TRANSCRIPTION FACTOR IN RENAL-CELL CARCINOMA LINES, The Journal of laboratory and clinical medicine, 131(3), 1998, pp. 261-268
Authors:
KURZROCK R
GRATWOHL A
PAQUETTE R
WYRES M
OKAMOTO D
YOUNG N
Citation: R. Kurzrock et al., TRILINEAGE RESPONSES SEEN WITH STEM-CELL FACTOR (STEMGEN(R), SCF) ANDFILGRASTIM (G-CSF) TREATMENT IN APLASTIC-ANEMIA (AA) PATIENTS (PTS), British Journal of Haematology, 102(1), 1998, pp. 2-2
Authors:
DIAMANDIDOU E
COLOMEGRIMMER M
FAYAD L
DUVIC M
KURZROCK R
Citation: E. Diamandidou et al., TRANSFORMATION OF MYCOSIS FUNGOIDES SEZARY-SYNDROME - CLINICAL CHARACTERISTICS AND PROGNOSIS/, Blood, 92(4), 1998, pp. 1150-1159
Authors:
KURZROCK R
Citation: R. Kurzrock, KI-LYMPHOMA AND INTERLEUKIN-6 - IN RESPONSE, Annals of internal medicine, 128(6), 1998, pp. 506-507
Authors:
KURZROCK R
Citation: R. Kurzrock, CYTOKINE DEREGULATION IN HEMATOLOGICAL MALIGNANCIES - CLINICAL AND BIOLOGICAL IMPLICATIONS, Clinical cancer research, 3(12), 1997, pp. 2581-2584
Authors:
KANTARJIAN HM
TALPAZ M
OBRIEN S
KURZROCK R
GUTTERMAN J
KEATING MJ
MCCREDIE KB
FREIREICH EJ
Citation: Hm. Kantarjian et al., CHRONIC MYELOGENOUS LEUKEMIA - PROGRESS AT THE M.-D.-ANDERSON-CANCER-CENTER OVER THE PAST 2 DECADES AND FUTURE-DIRECTIONS - FIRST FREIREICH,EMIL,J AWARD LECTURE, Clinical cancer research, 3(12), 1997, pp. 2723-2733
Authors:
CORTES J
KURZROCK R
Citation: J. Cortes et R. Kurzrock, INTERLEUKIN-10 IN NON-HODGKINS-LYMPHOMA, Leukemia & lymphoma, 26(3-4), 1997, pp. 251-259
Authors:
GISSLINGER H
KURZROCK R
WETZLER M
TUCKER S
KANTARJIAN H
ROBERTSON B
TALPAZ M
Citation: H. Gisslinger et al., APOPTOSIS IN CHRONIC MYELOGENOUS LEUKEMIA - STUDIES OF STAGE-SPECIFICDIFFERENCES, Leukemia & lymphoma, 25(1-2), 1997, pp. 121
Authors:
TALPAZ M
KANTARJIAN HM
OBRIEN S
KURZROCK R
Citation: M. Talpaz et al., THE M.D.-ANDERSON-CANCER-CENTER EXPERIENCE WITH INTERFERON-ALPHA THERAPY IN CHRONIC MYELOGENOUS LEUKEMIA, Bailliere's clinical haematology, 10(2), 1997, pp. 291-305
Authors:
SEYMOUR JF
TALPAZ M
KURZROCK R
Citation: Jf. Seymour et al., RESPONSE DURATION AND RECOVERY OF CD4(-ALPHA-RESISTANT HAIRY-CELL LEUKEMIA - 7-YEAR FOLLOW-UP() LYMPHOCYTES FOLLOWING DEOXYCOFORMYCIN IN INTERFERON), Leukemia, 11(1), 1997, pp. 42-47
Authors:
KURZROCK R
STROM SS
ESTEY E
OBRIEN S
KEATING MJ
JIANG H
ADAMS T
TALPAZ M
Citation: R. Kurzrock et al., 2ND CANCER RISK IN HAIRY-CELL LEUKEMIA - ANALYSIS OF 350 PATIENTS, Journal of clinical oncology, 15(5), 1997, pp. 1803-1810
Authors:
WETZLER M
KURZROCK R
ESTROV Z
BARONE S
ESTEY E
TALPAZ M
Citation: M. Wetzler et al., SUPPRESSED FORMATION OF BONE-MARROW ADHERENT LAYERS DERIVED FROM ACUTE MYELOID-LEUKEMIA PATIENTS AFTER IN-VITRO EXPOSURE TO INTERLEUKIN-4, Leukemia research, 21(6), 1997, pp. 519-527
Authors:
COHEN PR
KURZROCK R
Citation: Pr. Cohen et R. Kurzrock, MUCOCUTANEOUS PARANEOPLASTIC SYNDROMES, Seminars in oncology, 24(3), 1997, pp. 334-359
Authors:
COLOMEGRIMMER MI
DIAMANDIDOU E
FAUAD L
DUVIC M
KURZROCK R
Citation: Mi. Colomegrimmer et al., LARGE-CELL TRANSFORMATION IN MYCOSIS-FUNGOIDES - STUDY OF 26 CASES, Laboratory investigation, 76(1), 1997, pp. 230-230
Authors:
YOUNES A
AYOUB JP
SARRIS A
HAGEMEISTER F
NORTH L
PATE O
MCLAUGHLIN P
RODRIGUEZ MA
ROMAGUERA J
KURZROCK R
PRETI A
BACHIER C
SMITH T
CABANILLAS F
Citation: A. Younes et al., PACLITAXEL ACTIVITY FOR THE TREATMENT OF NON-HODGKINS-LYMPHOMA - FINAL REPORT OF A PHASE-II TRIAL, British Journal of Haematology, 96(2), 1997, pp. 328-332
Authors:
GISSLINGER H
GISSLINGER B
KURZROCK R
GRUMBECK E
TALPAZ M
Citation: H. Gisslinger et al., THE FAS-LIGAND IS NOT RESPONSIBLE FOR INTERFERON-INDUCED APOPTOSIS INDAUDI CELLS, Blood, 90(10), 1997, pp. 3477-3477
Authors:
DIAMANDIDOU E
COLOME M
FAYAD L
DUVIC M
KURZROCK R
Citation: E. Diamandidou et al., PROGNOSTIC FACTORS ANALYSIS IN MYCOSIS-FUNGOIDES SEZARY-SYNDROME, Blood, 90(10), 1997, pp. 3887-3887
Authors:
FAYAD L
CABANILLAS F
TALPAZ M
MCLAUGHLIN P
KURZROCK R
Citation: L. Fayad et al., HIGH SERUM INTERLEUKIN-6 LEVELS CORRELATE WITH A SHORTER FAILURE-FREESURVIVAL IN INDOLENT LYMPHOMAS, Blood, 90(10), 1997, pp. 3891-3891